Open AccessReply to the Letter to the editor “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD ”
Author(s) -
Takahashi Hirokazu,
Anzai Keizo
Publication year - 2022
Publication title -
hepatology communications
Language(s) - English
Resource type - Journals
ISSN - 2471-254X
DOI - 10.1002/hep4.1996
Subject(s) - medicine , liraglutide , type 2 diabetes , dyslipidemia , gastroenterology , glycemic , nonalcoholic fatty liver disease , diabetes mellitus , steatosis , fatty liver , steatohepatitis , endocrinology , insulin , disease